The present invention relates to methods and agents for treating impaired vascular and cardiac function. The liquid crystal composition contains a component which is a dielectrically positive component containing a dielectrically positive compound and a dielectrically neural component which exhibits dielectric anisotropy greater than \u22122 and smaller than +2. A second waveform can be determined by using pulse oximetry, Doppler velocimetry, measurement of arterial blood pressure and measurement of peripheral electrical bioimpedance or bioadmittance. A control subsystem may be an integral part of a luminaire or may be a retrofit. Each male contact male contact has a tower shaped to sealingly seat within an associated passage in the insulator. The body preferably has a heel aperture and a toe aperture.